Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

BACKGROUND: Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty for physicians, as it is hard to discriminate ILD from other causes of respiratory symptoms and to decide on safe treatment continuation. OBJECTIVE: We investigated the capability of pulmonary funct...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Target Oncol
Asıl Yazarlar: Willemsen, Annelieke E. C. A. B., Tol, Jolien, van Erp, Nielka P., Jonker, Marianne A., de Boer, Maaike, Meek, Bob, de Jong, Paul C., van Moorsel, Coline, Gerritsen, Winald R., Grutters, Jan C., van Herpen, Carla M. L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2019
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684805/
https://ncbi.nlm.nih.gov/pubmed/31325105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-019-00656-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller